• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化氢诱导枯否细胞激活:门静脉高压形成的新机制。

Kupffer cell activation by hydrogen peroxide: a new mechanism of portal pressure increase.

机构信息

Department of Medicine II (Gastroenterology and Hepatology), University of Munich-Grosshadern, Munich, Germany.

出版信息

Shock. 2010 Apr;33(4):412-8. doi: 10.1097/SHK.0b013e3181b85934.

DOI:10.1097/SHK.0b013e3181b85934
PMID:20118678
Abstract

This study aimed to investigate the effects of reactive oxygen species on the hepatic macrophages, the Kupffer cells (KC), and to identify the relevant targets of vasoconstrictors involved in the regulation of intrahepatic microcirculation and therefore portal pressure. The effects of hydrogen peroxide (H2O2), xanthine/xanthine oxidase or a thromboxane (TX) analogue (U46619; 0.1 microM) were tested in sham-operated and fibrotic livers (bile duct ligation over 4 weeks) during isolated rat liver perfusion and in vivo with or without additional KC blockade (gadolinium chloride, 10 mg kg(-1) body weight, 48 and 24 h, i.p.). To investigate downstream mechanisms, a TXA2 antagonist (BM 13.177; 20 microM) or a Rho kinase inhibitor (Y27632; 10 microM) was infused additionally. TXB2 efflux was measured by enzyme-linked immunosorbent assay. The phosphorylation state of moesin (p-moesin), as indicator for Rho kinase activity, was assessed by Western blot analyses. Portal pressure was dose-dependently increased by H2O2 (maximum, 0.5 mM) and, to a lower extent, by xanthine/xanthine oxidase together with catalase. The portal pressure increase by H2O2 was attenuated by previous KC blockade. TXA2 efflux increased after H2O2 infusion and was reduced by KC blockade. The TXA2 antagonist counteracted the H2O2-induced increase in portal pressure. The Rho kinase inhibitor attenuated portal pressure increase after TXA2 analogue or H2O2 infusion. Hepatic levels of p-moesin were increased after H2O2 infusion. Reactive oxygen species increased portal pressure via stimulation of TXA2 production by KCs and a subsequent Rho kinase-dependent contraction of the intrahepatic vasculature. In conclusion, the KCs that are well known to produce H2O2 could also be activated by H2O2. This vicious cycle may best be interrupted at the earliest time point.

摘要

本研究旨在探讨活性氧对肝巨噬细胞(枯否细胞)的影响,并确定参与调节肝内微循环和门静脉压的缩血管物质的相关靶点。在离体大鼠肝灌注和体内实验中,检测了过氧化氢(H2O2)、黄嘌呤/黄嘌呤氧化酶或血栓烷(TX)类似物(U46619;0.1μM)在假手术和纤维化肝脏(胆管结扎 4 周)中的作用,同时进行或不进行额外的 KC 阻断(氯化钆,10mgkg(-1)体重,腹腔内注射 48 和 24 小时)。为了研究下游机制,另外输注了 TXA2 拮抗剂(BM 13.177;20μM)或 Rho 激酶抑制剂(Y27632;10μM)。通过酶联免疫吸附试验测量 TXB2 外排。通过 Western blot 分析评估 moesin 的磷酸化状态(p-moesin),作为 Rho 激酶活性的指标。H2O2(最大浓度为 0.5mM)和黄嘌呤/黄嘌呤氧化酶与过氧化氢酶一起剂量依赖性地增加门静脉压力。H2O2 引起的门静脉压力升高可被 KC 阻断预先减轻。H2O2 输注后 TXA2 外排量增加,KC 阻断后减少。TXA2 拮抗剂可拮抗 H2O2 诱导的门静脉压力升高。Rho 激酶抑制剂可减轻 TXA2 类似物或 H2O2 输注后门静脉压力升高。H2O2 输注后肝内 p-moesin 水平增加。活性氧通过 KC 产生 TXA2 的刺激和随后的 Rho 激酶依赖性肝内血管收缩来增加门静脉压力。总之,众所周知的产生 H2O2 的 KC 也可被 H2O2 激活。这种恶性循环可能在最早的时间点被打断。

相似文献

1
Kupffer cell activation by hydrogen peroxide: a new mechanism of portal pressure increase.过氧化氢诱导枯否细胞激活:门静脉高压形成的新机制。
Shock. 2010 Apr;33(4):412-8. doi: 10.1097/SHK.0b013e3181b85934.
2
Amiloride reduces portal hypertension in rat liver cirrhosis.阿米洛利可降低肝硬化大鼠的门静脉高压。
Gut. 2010 Jun;59(6):827-36. doi: 10.1136/gut.2009.197756.
3
Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis.用白三烯抑制剂孟鲁司特治疗 10 天可减轻大鼠肝硬化门静脉高压。
Hepatology. 2010 Jun;51(6):2086-96. doi: 10.1002/hep.23596.
4
Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2).正常肝脏和纤维化肝脏中的库普弗细胞激活通过血栓素A2增加门静脉压力。
J Hepatol. 2007 Aug;47(2):228-38. doi: 10.1016/j.jhep.2007.03.019. Epub 2007 Apr 9.
5
Cyclooxygenase, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase MAPK, Rho kinase, and Src mediate hydrogen peroxide-induced contraction of rat thoracic aorta and vena cava.环氧化酶、p38丝裂原活化蛋白激酶(MAPK)、细胞外信号调节激酶MAPK、Rho激酶和Src介导过氧化氢诱导的大鼠胸主动脉和腔静脉收缩。
J Pharmacol Exp Ther. 2007 Jan;320(1):236-43. doi: 10.1124/jpet.106.110650. Epub 2006 Sep 26.
6
HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects.肝星状细胞特异性抑制 Rho-激酶可降低肝硬化大鼠的门静脉压而不产生主要的全身作用。
J Hepatol. 2012 Dec;57(6):1220-7. doi: 10.1016/j.jhep.2012.07.033. Epub 2012 Aug 6.
7
The effects of hepatic steatosis on thromboxane A induced portal hypertension.肝脂肪变性对血栓素A诱导的门静脉高压的影响。
Gastroenterol Hepatol. 2019 Nov;42(9):534-541. doi: 10.1016/j.gastrohep.2019.03.015. Epub 2019 Jul 17.
8
Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis.RhoA和Rho激酶信号通路在肝内的上调导致继发性胆汁性肝硬化大鼠肝血管阻力增加。
Gut. 2006 Sep;55(9):1296-305. doi: 10.1136/gut.2005.081059. Epub 2006 Feb 21.
9
LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liver.脂多糖加剧内皮素-1诱导的前纤维化大鼠肝脏库普弗细胞胞质磷脂酶A2的激活及血栓素A2的生成。
J Hepatol. 2007 Feb;46(2):276-85. doi: 10.1016/j.jhep.2006.08.026. Epub 2006 Nov 29.
10
Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats.来自库普弗细胞的血栓素A2导致内毒素血症大鼠肝门循环对内皮素-1的高反应性。
Am J Physiol Gastrointest Liver Physiol. 2005 Feb;288(2):G277-83. doi: 10.1152/ajpgi.00256.2004.

引用本文的文献

1
From liver fibrosis to hepatocarcinogenesis: Role of excessive liver HO and targeting nanotherapeutics.从肝纤维化到肝癌发生:肝脏中过量血红素加氧酶的作用及靶向纳米疗法
Bioact Mater. 2022 Nov 12;23:187-205. doi: 10.1016/j.bioactmat.2022.11.001. eCollection 2023 May.
2
Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension.非肝硬化和肝硬化门静脉高压患者巨噬细胞活化标志物可溶性CD163和甘露糖受体的差异
Front Physiol. 2021 Jun 11;12:649668. doi: 10.3389/fphys.2021.649668. eCollection 2021.
3
Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.
急性-on-慢性肝衰竭:发病机制、预后因素及管理。 注:原文中“Acute-on-chronic”表述不太准确,可能是“acute-on-chronic”,准确意思是“慢加急性”。完整准确译文应该是:慢加急性肝衰竭:发病机制、预后因素及管理。
World J Gastroenterol. 2015 Nov 14;21(42):12125-40. doi: 10.3748/wjg.v21.i42.12125.
4
The role of chemokines in acute liver injury.趋化因子在急性肝损伤中的作用。
Front Physiol. 2012 Jun 20;3:213. doi: 10.3389/fphys.2012.00213. eCollection 2012.
5
Bench-to-beside review: acute-on-chronic liver failure - linking the gut, liver and systemic circulation.从基础到床边的综述:慢加急性肝衰竭——连接肠道、肝脏和全身循环。
Crit Care. 2011;15(5):233. doi: 10.1186/cc10424. Epub 2011 Oct 25.